MORGAN ADAM purchased 55.3% of their position (2.49M shares) of HERON THERAPEUTICS, INC. /DE/ on the open market
Open‑market purchase worth $3.41M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/25/2023ACC: 0000921895-23-001721
+3.65M
Net shares
Net buyer
$3.41M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
3.65M acquired
Non-Derivative Transactions1
Common Stock, par value $0.01 per share
Indirect
Shares
+2.49M
Price / share
$1.37
Trade value
$3.41M
% of position
55.3%
7/21/2023
4.50M→6.99M
Total
Net shares
+2.49M
Net value
$3.41M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share Indirect | 7/21/2023 | P · Purchase | +2.49M | $1.37 | $3.41M | 55.3% | 4.50M | 6.99M |
| Total | +2.49M | $3.41M | ||||||
Derivative Transactions1
Pre-funded Warrants to Purchase Common Stock
Indirect
Converts to
Common Stock, par value $0.01 per share
1.16M shares
Shares
+1.16M
Strike price
0.0001
Held after
1.16M
Exercisable
—
7/21/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Pre-funded Warrants to Purchase Common Stock Indirect | Common Stock, par value $0.01 per share1.16M shares | 7/21/2023 | P · Purchase | +1.16M | 0.0001 | — | 1.16M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock, par value $0.01 per share
DirectShares owned37.88K
Total
37.88K direct37.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.01 per share | 37.88K | Direct |
| Total | 37.88K | 37.88K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported